StonvexLoading…
StonvexStonvexStonvexCore line items from HRMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $215.39M | $868.45M | $624.68M | $385.22M |
Operating Income | $37.29M | $208.47M | $169.91M | $104.42M |
Net Income | $32.49M | $158.69M | $136.20M | $85.34M |
EPS (Diluted) | $0.55 | $2.71 | $2.32 | $1.46 |
Total Assets | $1.27B | $1.27B | $1.21B | $1.11B |
Total Liabilities | $361.48M | $401.41M | $373.10M | $334.93M |
Cash & Equivalents | $589.40M | $752.50M | $647.00M | $546.05M |
Free Cash Flow OCF − CapEx | Not available | $347.89M | $221.84M | $113.18M |
Shares Outstanding | 57.87M | 57.73M | 57.60M | 57.54M |